EuroTimes Breaking News

Date Posted 15/09/2009
New OCT Devices incorporate Heidelberg Engineering’s BluePeak™ technology
Heidelberg Engineering has announced two new additions to the SPECTRALIS® family of multi-modality ophthalmic imaging devices. The new models add BluePeak laser autofluorescence to the company’s more economical spectral-domain OCT (SD-OCT) devices.
“BluePeak autofluorescence adds a functional indicator of retinal health by measuring the metabolic activity of the RPE,” said Karl Csaky MD, PhD, Retina Foundation of the Southwest.
“Recent results from the Geographic Atrophy Progression (GAP) study clearly demonstrate the need to use autofluorescence to track the progression of geographic atrophy for dry AMD patients.
"This has attracted the interest of the pharmaceutical companies; at least 10 new therapies for dry AMD are now under clinical investigation. The combination of BluePeak and OCT will enable clinicians to potentially take advantage of these emerging therapeutics in the same way that ranibizumab and OCT changed the management of wet AMD,” said Dr Csaky.
BluePeak laser autofluorescence is now available on five of the SPECTRALIS models.
“The SPECTRALIS imaging platform was designed to be modular,” said Carole McCallum, marketing manager for Heidelberg Engineering. “These new models demonstrate our ability to incorporate new imaging technology into our existing platform and offer clinicians more utility and value with the multi-modality design.”
There are now seven different SPECTRALIS models available. The main differences between the models are which of the available imaging modalities they include, whether the instrument is set up for Wide Field imaging, and hardware upgrade options. Product line details are available
at www.HeidelbergEngineering.com





eTIMES newsletter
eTIMES is a new bi-monthly newsletter with the latest breaking news from the ESCRS and the world of ophthalmology.
Media Guide 2010
Results from our readership survey plus information about advertising in EuroTimes
Podcasts
Eye Contact features interviews with key opinion leaders in the world of ophthalmology
Tuesday, 07 September 2010
www.eurotimes.org